--- title: "Daniel Ek's Neko Health charges $499 a scan, 8.3 times BodySpec's $59.95 DEXA; the follow-up bill is unpriced" description: "Neko Health's first US clinic charges $499 cash for an hour of scanning, 8.3 times BodySpec's $59.95 DEXA floor, while the follow-up bill for the 1 in 100 it flags lands somewhere else entirely." publisher: "The Inference" section: "Health" published: 2026-11-02T20:06:46.280Z modified: 2026-11-02T20:06:46.280Z canonical: https://theinference.org/article/daniel-ek-s-neko-health-charges-499-a-scan-8-3-times-bodyspec-s-59-95-dexa-the-follow-up-bill-is-unpriced language: en keywords: "Body Scans, Consumer Health, Health Tech, Startups" --- # Daniel Ek's Neko Health charges $499 a scan, 8.3 times BodySpec's $59.95 DEXA; the follow-up bill is unpriced > Neko Health's first US clinic charges $499 cash for an hour of scanning, 8.3 times BodySpec's $59.95 DEXA floor, while the follow-up bill for the 1 in 100 it flags lands somewhere else entirely. Daniel Ek got people to pay for music they used to pirate [1]. Now the [Spotify](https://theinference.org/markets/companies/spotify) co-founder wants them to pay $499 to look at their own bodies [2][3]. His company, Neko Health, opened its first US clinic in SoHo on September 24, 2026, after [more than 25,000 New Yorkers queued ahead of launch](https://finance.yahoo.com/healthcare/articles/neko-health-opens-doors-york-110000569.html); the line has since passed 50,000 [2][3]. The question the waitlist hides is the one the whole category rides on: is prevention a product people buy twice, or a scan they buy once? ## The money on the table, and the floor under it Neko's hour costs $499: a 53-marker blood panel, more than 6,000 photos of the skin that AI screens for suspicious moles, a heart and circulation check, and a clinician's walkthrough before you leave [2]. Insurance does not pay, though health savings accounts cover it [1]. The floor beneath that price is [BodySpec](https://theinference.org/markets/companies/bodyspec)'s mobile DEXA scan, an X-ray test of fat, muscle and bone sold out of vans for about a decade at around $50 [1]. [BodySpec's own price list](https://www.bodyspec.com/pricing) now shows $59.95 for one baseline scan, done in under 15 minutes, or $39.95 a month on a membership [4]. Between floor and ceiling sits the cash-pay ladder: Function Health's $365 annual membership buys two blood panels a year, about $182 per panel, fresh off a [$450 million raise from General Catalyst's Customer Value Fund](https://www.inc.com/lucia-auerbach/function-just-raised-450-million-dollars-ceo-says-no-competitors-in-the-space/91390605) [5]; Prenuvo charges $2,499 for a whole-body MRI [1]. Neko sells neither the cheapest test nor the deepest one. It sells the hour. *Chart: **Neko's $499 sits about eight times above the $60 floor of cash-pay scanning** Horizontal bar chart of four cash-pay body-scan price points, all per visit: BodySpec DEXA $59.95, Function Health about $182.50 per panel, Neko Health $499 per scan, Prenuvo whole-body MRI $2,499. Neko highlighted.* *US cash-pay prices on a per-visit basis as published: BodySpec's own pricing page (November 2, 2026), Function Health's $365 annual membership split across the two panels a year it includes, about $182.50 each, per Inc. August 20, 2026, Prenuvo via Quartz, November 2, 2026. Products differ: DEXA measures body composition only, Function and Neko are blood-panel checkups, Prenuvo is whole-body MRI. [4][5][1]* ## What $960 million of venture money bought The sum in the subhead is two rounds: a $260 million Series B in January 2025 and a $700 million Series C in July 2026, co-led by [Lightspeed](https://theinference.org/markets/companies/lightspeed) Venture Partners, with [Mark Zuckerberg](https://theinference.org/markets/people/mark-zuckerberg) and Priscilla Chan among the names attached [6]. The category has buried its ancestors. Theranos promised answers from a finger prick and collapsed into a fraud conviction, and Jawbone, once valued at $3 billion, liquidated in 2017 [1]. The capital is underwriting repeat visits, and on that score Neko's numbers are the best published in the category: [75% of members prepay for their next scan at the end of their first appointment](https://www.fiercehealthcare.com/health-tech/full-body-scan-startup-neko-health-scores-700m-break-us-market), 80% after the second [6]. More than 100,000 people have been scanned across Sweden and the UK [2]. Demand is not in doubt: the second New York site, at Brookfield Place, opens in January 2027 [3]. *Chart: **Venture money is betting on repeat scans, not one-time buyers** Horizontal bar chart of three recent raises in cash-pay scanning: Neko Health $700 million Series C (July 2026), Function Health $450 million growth round (August 2026), Prenuvo $120 million (2025). Neko highlighted.* *Most recent disclosed rounds, in US dollars: Neko Health $700M Series C co-led by Lightspeed, via Fierce Healthcare, July 15, 2026; Function Health $450M from General Catalyst's Customer Value Fund, via Inc., August 20, 2026; Prenuvo $120M in 2025, via Fierce Healthcare. Neko also raised $260M in January 2025, per Fierce Healthcare. [6][5]* ## The 1% who find out, and the bill that follows Here is the complication. After more than 100,000 scans, Ek says [about 1% of members had a serious undiagnosed condition](https://qz.com/neko-health-daniel-ek-body-scans), and Neko presents that as proof the product works [1]. Finding a condition is not the same as extending a life. The $499 buys the discovery; the diagnostics, the dermatologist and the treatment afterwards land on the patient or their insurance, and Neko hands members off to Mount Sinai, Columbia and other vetted systems [2]. Business Insider's reporter was one of the fewer than one in ten customers referred out, a week and a half after her scan, for a mole a dermatologist should see [7]. Her verdict on the rest: if she had $500 extra to spend on her health, she would start with a gym membership, then consider a DEXA scan [7]. The waitlist is made of people who disagree with her. Both things are true, and the follow-up bill is the part nobody prices. ## The market's verdict is still pending The public test is Oura, the smart ring maker, which filed to go public in late September and then [postponed the IPO on September 29, 2026](https://www.forbes.com/sites/siladityaray/2026/09/29/smart-ring-maker-oura-postpones-ipo-blames-market-uncertainty/), despite 5.7 million paying members and 90% expected revenue growth for fiscal 2026; the filing had sought $2.2 billion at a fully diluted valuation near $15.6 billion [8]. Oura blamed market uncertainty, not weak numbers [8]. Until it lists, there is no public price for any of this. Meanwhile a 2024 JAMA study found 40% of Americans wear a tracker, and a primary care doctor who treats homeless patients told the New York Times her patients wear none, because data only helps people with the money and agency to act on it [1]. Ek diagnosed insurers correctly: they will not fund a payoff that takes 10 to 20 years [1]. That is why the scan lives on wallets instead. The number to watch is Neko's second-scan retention in the US, not the waitlist. A waitlist proves curiosity. Renewal proves a business. ## What decides it next Miami and the second New York site at Brookfield Place, set for January 2027, come next [7][3], and Washington DC and San Francisco are on the plan [2]. Oura's bankers get another window to reprice the category [8]. If Oura lists near $15 billion on 5.7 million subscribers, every scan investor reprices off that print [8]. If it cannot, the private marks, Neko's reported $7 billion included [3], will be standing on the last buyer's bid. A scan company is only a subscription if people come back without being frightened into it. Neko's 75% says they do, in Europe, on their own dime [6]. New York gets to say whether that was Sweden, or just the product. ## Takeaway Neko's $499 scan sits 8.3 times above BodySpec's $59.95 DEXA floor, and its $960 million of funding rests on whether US members prepay for a second scan the way 75% of European ones have. ## Sources 1. [Quartz, Spotify's founder wants to scan you, 2 November 2026](https://qz.com/neko-health-daniel-ek-body-scans) 2. [PR Newswire via Yahoo Finance, Neko Health opens its doors in New York, 24 September 2026](https://finance.yahoo.com/healthcare/articles/neko-health-opens-doors-york-110000569.html) 3. [New York Post, Body-scan startup Neko Health draws Karlie Kloss, Paris Hilton in new health craze, 14 October 2026](https://nypost.com/2026/10/14/business/body-scan-startup-neko-health-draws-karlie-kloss-paris-hilton-in-new-health-craze/) 4. [BodySpec, Pricing page, fetched 2 November 2026](https://www.bodyspec.com/pricing) 5. [Inc., Function Just Raised $450 Million. Its CEO and Co-Founder Says It Has No Competitors, 20 August 2026](https://www.inc.com/lucia-auerbach/function-just-raised-450-million-dollars-ceo-says-no-competitors-in-the-space/91390605) 6. [Fierce Healthcare, Full-body scan startup Neko Health scores $700M to break into the U.S. market, 15 July 2026](https://www.fiercehealthcare.com/health-tech/full-body-scan-startup-neko-health-scores-700m-break-us-market) 7. [Business Insider via Yahoo, I tried the new body scan that promises to spot cancer and heart disease signs in under an hour, 24 September 2026](https://www.yahoo.com/lifestyle/articles/neko-scan-spotify-longevity-designed-110001421.html) 8. [Forbes, Smart Ring Maker Oura Postpones IPO, Blames Market Uncertainty, 29 September 2026](https://www.forbes.com/sites/siladityaray/2026/09/29/smart-ring-maker-oura-postpones-ipo-blames-market-uncertainty/) --- Daniel Ek's Neko Health charges $499 a scan, 8.3 times BodySpec's $59.95 DEXA; the follow-up bill is unpriced — The Inference. Canonical: https://theinference.org/article/daniel-ek-s-neko-health-charges-499-a-scan-8-3-times-bodyspec-s-59-95-dexa-the-follow-up-bill-is-unpriced